#31
|
||||
|
||||
Òàì êàêîé-òî ÷åðâÿê - W32/IrcMox. Ñòðààøíî.
|
#32
|
|||
|
|||
Ýòî àäðåñ ñàéòà àâòîðîâ ïðîãðàììû. Âîò ÷òî îíè ïèøóò:
Òàêæå, ðàçüÿñíåíèå ïî ïîâîäó "âèðóñà" â äèñòðèáóòèâå. Êàêîé-òî ëåâûé àíòèâèðóñ (F-Prot 3.15b) óæå äàâíî âèäèò â íàøåì äèñòðèáóòèâå ÷åðâÿêà - W32/IrcMox. Ïîëüçóéòåñü, ïîæàëóéñòà, íîðìàëüíûìè ïðîäóêòàìè - Àíòèâèðóñîì Êàñïåðñêîãî èëè Norton Antivirus. Ò.å. âèðóñà òàì íåò, êà÷àéòå íà çäîðîâüå! |
#33
|
|||
|
|||
Óâàæàåìàÿ Åëåíà,
ÿ ïðèâåòñòâóþ âîçìîæíîñòü îáùåíèÿ ñ Âàìè, - ïðåêðàñíî, åñòü æåëàíèå îáñóäèòü âåäåíèå ðîäîâ ó áåðåìåííûõ ïîñëå ïðåäøåñòâóþùåãî êåñàðåâà. Çà ïðîøåäøèå 10 ëåò, åññíî, îïûò âåäåíèÿ ïîäîáíûõ ïàöèåíòîê ïðèáàâèëñÿ, â ñîâðåìåííûõ ðîääîìàõ ñòàë ðóòèíîé â ñàìîì çàìå÷àòåëüíîì ñìûñëå ýòîãî ñëîâà, à âîò ÓÇÈ - íå òàêîé óæ ïëîõîé ìåòîä , äëÿ îöåíêè íàëè÷èÿ äåôåêòîâ ðóáöà à íå òîëùèíó åãî ñòåíêè. [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] Åñëè ýïèäóðàëüíàÿ àíåñòåçèÿ - ýòî ïîâñåäíåâíàÿ äåÿòåëüíîñòü âàøåé êëèíèêè, òî íåïëîõî áû ïîñìîòðåòü, ÷òî äóìàåò ïî ýòîìó ïîâîäó îñòàëüíîå ÷åëîâå÷åñòâî, à âîò áåçáîëåâàÿ ôîðìà ðàçðûâà ìàòêè ïî ðóáöó î÷åâèäíî, èìååò ïðàâî íà ÷èñòî òåîðåòè÷åñêîå ñóùåñòâîâàíèå?  ïðèíöèïå, ñóùåñòâóåò ëè÷íî ìíå ñèìïàòè÷íîå ìíåíèå, (Ïî ïîâîäó îêñèòîöèíà è ïðîñòàãëàíäèíîâ), ÷òî íà÷èíàÿ ñòèìóëÿöèþ îêñèòîöèíîì ïåðñîíàë îáÿçàí ÷àùå êîíòðîëèðîâàòü ïàöèåíòêó, ÷åì ïîñëå ââåäåíèÿ ïðîñòàãëàíäèíîâ, òî åñòü èäåÿ â ñëåäóþùåì ñêîðåå èìåííî áîëåå âíèìàòåëüíîå îòíîøåíèå è áóäåò ïðîôèëàêòèêîé îñëîæíåíèé. È, êàêèì îáðàçîì Âû óçíàëè î ÐÌÑ? |
#34
|
|||
|
|||
Äîðîãàÿ Òàòüÿíà,
Êîíå÷íî ÓÇÈ ìîæåò ïîìî÷ü îïðåäåëòü òîëùèíó ðóáöà, îá ýòîì è ïèøóò â ñòàòüå, êîòîðóþ âû ìíå ïðèñëàëè. Íî âåäü íà ñàìîì äåëå íàñ èíòåðåñóåò ñîâñåì äðóãîé âîïðîñ. À èìåííî, êàêîâ ðèñê êëèíè÷åñêè çíà÷èìîãî ðàçðûâà ìàòêè â ðîäàõ ïðè èñòîí÷åíèè ðóáöà? ß òàêèõ èñëåäîâàíèé íå âèäåëà. Íàñ÷åò ýïèäóðàëüíîé àíåñòåçèè, òî ýòî íå ïðàêòèêà "íàøåé êëèíèêè". Ýòî óñòîÿâøàÿñÿ ïðàêòèêà âñåé Ñåâåðîé Àìåðèêè êàê ìèíèìóì. Áåçáîëåâûå ðàçðûâû ìàòêè êîíå÷íî áûâàþò, íî ãîðàçäî ÷àùå áûâàþò âñå-òàêè áîëåçíåíûå ðîäû. È êàê îäíî îò äðóãîãî îòè÷èòü - òðóäíî ñêàçàòü. Êàê ïðàâèëà ïåðâûìè ïðèçíàêàìè ðàçðûâà ÿâëÿþòñÿ èçìåíåíèÿ ïðè êàðäèîòîêî ìîíèòîðèðîâàíèè. Íàäî ìíå ïîèñêàòü ñòàòüè íà ýòó åìó. Î òîì,òî ýïèäóðàëüíé àíåñòåçèè - áûòü,ðåøëè çàäîëãî äî òîãî,êàê ÿ íà÷àëà ðàáîòàòü. Ýòîò âîïðîñ óæå äàâíî íå îáñóæäàåòñÿ. Î ïðîñòàãëàíäèíàõ - ìíîãèå èññëåäîâàíèÿ ïîêàçàëè, ÷òî ïðîñòàãëàíäèíû çíà÷èòåëüíî, ãäå-òî â 4 ðàçà, ïîâûøàþò ðèñê ðàçðûâà ìàòêè, ïîýòîìó îíè íåïðèåìëèìû. Äåëî íå â íàáëþäåíèè. Íàáëþäåíèå âåäü çà âñåìè îäèíàêîâîå,ïîñòîÿííîå,íà âñå êîìïüòðû âûâîäèòñÿ ChildWatch,è åñëè ÷òî ñðàáàòûâàåò ñèðåíà :-). Ñïàñèáî âñåì áîëüøîå çà ññèëêó íà [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] Painfull, ... but at least I can write in Russian. Maybe after I practice some it will get better... Happy Holidays. Öèòàòà:
|
#35
|
|||
|
|||
This are just guidelines, but still may be usefull...
Guidelines for vaginal birth after previous Cesarean birth. [Article in English, French] Martel MJ, MacKinnon CJ; Clinical Practice Obstetrics Committee of the Society of Obstetricians and Gynaecologiests of Canada. OBJECTIVE: To provide evidence-based guidelines for the provision of a trial of labour (TOL) after Caesarean section. OUTCOME: Fetal and maternal morbidity and mortality associated with vaginal birth after Caesarean (VBAC) and repeat Caesarean section. EVIDENCE: MEDLINE database was searched for articles published from January 1995 to February 2004, using the key words "vaginal birth after Caesarean (Cesarean) section." The quality of evidence is described using the Evaluation of Evidence criteria outlined in the Report of the Canadian Task Force on the Periodic Health Exam. RECOMMENDATIONS: 1. Provided there are no contraindications, a woman with 1 previous transverse low-segment Caesarean section should be offered a trial of labour after Caesarean with appropriate discussion of maternal and perinatal risks and benefits. The process of informed consent with appropriate documentation should be an important part of the birth plan in a woman with a previous Caesarean section. (II-2B) 2. The intention of a woman undergoing a TOL after Caesarean should be clearly stated and documentation of the previous uterine scar should be clearly marked on the prenatal record. (II-2B) 3. For a safe labour after Caesarean section, the woman should deliver in a hospital where an immediate Caesarean section is available. The woman and her health-care provider must be aware of the hospital resources and the availability of obstetric, anaesthesia, pediatric, and operating-room staff. (II-2A) 4. Each hospital should have a written policy in place regarding the notification and/or consultation for the physicians responsible for a possible immediate Caesarean. (III B) 5. Continuous electronic fetal monitoring of women attempting a TOL after Caesarean is recommended. (II-2A) 6. Suspected uterine rupture requires urgent attention and expedited laparotomy in order to attempt to decrease maternal and perinatal morbidity and mortality. (II-2A) 7. Oxytocin augmentation is not contraindicated in women undergoing a TOL after Caesarean. (II-2A) 8. Medical induction of labour with oxytocin may be associated with an increased risk of uterine rupture and should be used carefully after appropriate counselling. (II-2B)9. Medical induction of labour with prostaglandin E2 (dinoprostone) is associated with an increased risk of uterine rupture and should not be used except in rare circumstances after appropriate counselling. (II-2B) 10. Prostaglandin E1 (misoprostol) is associated with a high risk of uterine rupture and should not be used as part of a TOL after Caesarean. (II-2A) 11. A foley catheter may be used safely to ripen the cervix in a woman planning a TOL after Caesarean. (II-2A) 12. The available data suggest that a trial of labour in women with more than one previous Caesarean section is likely to be successful but is associated with a higher risk of uterine rupture. (II-2B) 13. Multiple gestation is not a contraindication to a TOL after Caesarean. (II-2B) 14. Diabetes mellitus is not a contraindication to TOL after Caesarean. (II-2B) 15. Suspected fetal macrosomia is not a contraindication to a TOL after Caesarean. (II-2B) 16.Women delivering within 18 to 24 months of a Caesarean section should be counselled about an increased risk of uterine rupture in labour. (II-2B) 17. Postdatism is not a contraindication to a TOL after Caesarean. (II-2B) 18. Every effort should be made to obtain the previous Caesarean section operative report to determine the type of uterine incision used. In situations where the scar is unknown, information concerning the circumstances of the previous delivery is helpful in determining the likelihood of a low transverse incision. If the likelihood of a lower transverse incision is high, TOL after Caesarean can be offered. (II-2B) VALIDATION: These guidelines were approved by the Clinical Practice Obstetrics and Executive Committees of the Society of Obstetricians and Gynaecologists of Canada. Publication Types: · Guideline · Practice Guideline PMID: 15248936 [PubMed - indexed for MEDLINE] Committee opinion. Induction of labor for vaginal birth after cesarean delivery. ACOG Committee on Obstetric Practice. A recent population-based study of vaginal birth after cesarean delivery (VBAC) attempts observed uterine rupture rates of 24.5 per 1,000 with prostaglandin-induced labor, while the uterine rupture rates with spontaneous labor and labor induced without prostaglandins were lower (5.2/1,000 and 7.71/1,000 respectively). The authors did not confirm the diagnoses by examining individual medical records, so the actual incidence of uterine rupture may have been overstated. Despite this limitation, the Committee on Obstetric Practice concludes that the risk of uterine rupture during VBAC attempts is substantially increased with the use of various prostaglandin cervical ripening agents for the induction of labor, and their use for this purpose is discouraged. |
#36
|
||||
|
||||
Ïðî÷èòàëà ÿ ýòó òåìó è ïîäóìàëà...äà..ÿ êîíå÷íî ïðèñîåäèíÿþñü ê ïîçäðàâëåíèÿì!!!!!!!!! Çàìå÷àòåëüíî ÷òî âñå õîðîøî êîí÷èëîñü!!! Íî........
Ó íàñ â ãîðîäå òàêèõ æåíùèí ïðåäïî÷èòàþò ðîäîðàçðåøàòü ïóòåì êåñàðåâà ñå÷åíèÿ...òàê êàê ìåðó ñîñòîÿòåëüíîñòè ðóáöà îöåíèòü î÷åíü ñëîæíî..õîòÿ è ñóùåñòâóþò è ÓÇÈ è äðóãèå îáúåêòèâíûå ìåòîäû îöåíêè... Êîíå÷íî, â áîëüøèíñòâå ñâîåì âñå ìû ïåðåñòðàõîâùèêè(àêóøåðû-ãèíåêîëîãè), íî ëó÷øå 10 æåíùèí ïðîêåñàðèòü ÷åì ïîòåðÿòü îäíó, ðåøèâøèñü âåñòè ðîäû êîñåðâàòèâíî...áûëè â ìîåé ïðàêòèêå òàêèå ñëó÷àè... |
#37
|
|||
|
|||
Ya vas ponimayu, konechno. No v Rossi zhenshini v osnovnom imeyut 2-3 detei, a to i odnogo. U nas sovsem drugaya situaziya. Esli zhenshina khochet imet' 2-3 detei mi ei i ne predlagayem VBAC. A kak naschet 6-8 detei? C-section #6 inogda eshe opasnee chem VBAC. Chasto pri grand multiparity vstrechayetsya placenta acreta i percreta, ya v Rossii voobshe nikogda takogo ne videla. A tut mi nedavno u odnoi barishni pri c-section #5 obnaruzhili nediagnostirovannuyu placentu percreta - posle 25!!! untov krovi (PRBC's), 5 plasmi, 5 trombozitov i factora 7, kotorii prislal sosednii hospital' -stoit 12000$ odin unit, reseczii mozhevogo pusirya, pazietnka vizhila i ushla domoi cheres 5 dnei. No - eto prosto chudo, chto ona vizhila...Ne snayu, chtobi mi s nei v Rossii delali. Vot i podumayesh', chto luchshe.
Öèòàòà:
|
|
#38
|
||||
|
||||
Åëåíà!! Êñîæàëåíèþ íå çíàþ Âàø îïûò ðàáîòû â Ðîññèè, âñòðå÷àþòñÿ êîíå÷íî è òàêèå ñëó÷àè...âðà÷è Ðîññèè ãåðîè÷åñêè áîðÿòñÿ â òàêèõ ñèòóàöèÿõ...òàêòèêà îäíà-ýêñòèðïàöèÿ ìàòêè(ê ñîæàëåíèþ). À íàñ÷åò ìíîæåñòâåííûõ îïåðàöèé êåñàðåâà ñå÷åíèÿ-ó íàñ ïîñëå 3é îïåðàöèè â îáÿçàòåëüíîì ïîðÿäêå äåëàþò ñòåðèëèçàöèþ, òàê ÷òî â Ðîññèè íå çàáàëóåøü
|
#39
|
|||
|
|||
À åñëè äàìà êàòåãîðè÷åñêè ïðîòèâ ñòåðèëèçàöèè?
|
#40
|
||||
|
||||
Êàê ýòî â îáÿçàòåëüíîì ïîðÿäêå? Êòî êîãî îáÿçûâàåò?
|
#41
|
|||
|
|||
Ê ñîæàëåíèþ Äîêòîðêà ïðàâà è ñóùåñòâóåò òàêàÿ î÷åðåäíàÿ óñòàíîâêà-íå çíàþ êåì ïðèäóìàíà-âî âðåìÿ 3 êåñàðåâîãî ïåðåâÿçûâàþòñÿ òðóáû.
|
#42
|
||||
|
||||
À ïàöèåíòêè äàþò íà ýòî ïèñüìåííîå ñîãëàñèå?
|
#43
|
|||
|
|||
Ïàöèåíòêó ñòàâÿò â èçâåñòíîñòü î ïðåäñòîÿùåé ñòåðèëèçàöèè? È ÷òî ïðîèñõîäèò, åñëè ïàöèåíòêà êàòåãîðè÷åñêè ïðîòèâ?
|
#44
|
||||
|
||||
Öèòàòà:
|
#45
|
||||
|
||||
Íäà... à ÿ äóìàëà, ýòî òîëüêî â íàøåì äåëå ãëàâíîå - èñïóãàòü.
__________________
Lead, follow, or get out of the way. — Thomas Paine |